Rho kinase-mediated vasoconstriction in rat models of pulmonary hypertension (Q46675976)

24 December 2017

title

Rho kinase-mediated vasoconstriction in rat models of pulmonary hypertension (English)

1 reference

24 December 2017

1 reference

Masahiko Oka

1

1 reference

24 December 2017

Noriyuki Homma

series ordinal

2

1 reference

24 December 2017

Ivan F McMurtry

series ordinal

3

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

24 December 2017

number of pages

14

1 reference

inferred from page(s)

published in

Methods in Enzymology

1 reference

24 December 2017

volume

439

1 reference

24 December 2017

page(s)

191-204

1 reference

24 December 2017

The COOH terminus of Rho-kinase negatively regulates rho-kinase activity.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Role of hemodynamics in pulmonary vascular remodeling: implications for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Targeting Rho and Rho-kinase in the treatment of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Pulmonary Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Structural basis of hypoxic pulmonary hypertension: the modifying effect of chronic hypercapnia.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Cellular and molecular pathobiology of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Molecular biology of primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Distinct pathways of Ca(2+) sensitization in porcine coronary artery: effects of Rho-related kinase and protein kinase C inhibition on force and intracellular Ca(2+).

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Invited review: regulation of myosin phosphorylation in smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Pathologic assessment of vasculopathies in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Primary pulmonary hypertension. A national prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Mediators and modulators of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Rho activation in excitatory agonist-stimulated vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Calcium sensitivity and agonist-induced calcium sensitization in small arteries of young and adult spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Rho-kinase is an important therapeutic target in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Signal transduction and regulation in smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Pulmonary and systemic vascular responsiveness to TNF-alpha in conscious rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Development of specific Rho-kinase inhibitors and their clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Hyperosmotic-induced protein kinase N 1 activation in a vesicular compartment is dependent upon Rac1 and 3-phosphoinositide-dependent kinase 1

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

Vascular endothelial growth factor in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2900415-6

7 January 2021

10.1016/S0076-6879(07)00415-6

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017